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Migration of contraceptive implant
Foreign bodyThe case is about an 18 year-old woman who beneﬁted of a radiopaque contraceptive implant (Nexplanon)
inserted in the left arm. When she wanted to remove it, it couldn't be found by palpation, US, CT and MRI. A
CXR and a thoracic CT scan were necessary to locate the implant, and the implant was removed by endovascular
procedures.
Signiﬁcant migration of a contraceptive implant is uncommon, and only one case ofmigration far from the inser-
tion limb has been reported. Using radiopaque contraceptive implants like Nexplanon could locate them easier if
a migration occurs.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
An 18 year-old woman, without medical history, requested a
contraceptive implant. The insertion of a Nexplanon device in the
left upper limb was immediately followed by an important local
hematoma.
Five months later, as the patient was complaining about local
pain, a removal was proposed. The implant could not be located nei-
ther clinically nor following ultrasonography. Hormone assays were
positive, conﬁrming that the implant was present in the patient's
body.
Complementary radiography, CT and MRI were performed but
failed in locating the implant, despite a scanning covering all left
upper limb.
At last, a chest radiograph was performed looking for a possible
migration. It showed a linear opaque structure in the pulmonary
hemi-right ﬁeld, whose size and shape were compatible with the
Nexplanon (Figs. 1-2). A contrast-enhanced thoracic CT scan con-
ﬁrmed the migration and speciﬁed its location in the upper right
lobar artery, extending into the apical segmental artery, withes), valerie.laigle@chu-nantes.fr
. This is an open access article underassociated arterial stenosis (Fig. 3). Retrieval of the embolized device
was decided.
The implant was removed by percutaneous interventional tech-
nique through a right femoral vein access. The device was captured
with a loop snare after mobilization without complication (Figs. 4–
5).
2. Discussion
The Nexplanon is a long-active progestogen-only contraceptive
method that contains 68mg etonogestrel. It is a very efﬁcient contra-
ceptive method (Pearl Index 0) [1], with irregular periods as main
side effect. The subcutaneous implant is radiopaque, contrary to
the Implanon device.
Signiﬁcant migrations (N2 cm) are uncommon, and primarily
occur caudally looking to the insertion site [2]. Other previously
described side effects at the time of the removal are deep insertion,
ﬁbrous adhesions and broken implant. Their prevalence is about 1%
[3].
In our case, we think that an inadvertent placement of the
Nexplanon into the basilic vein occurred during the initial proce-
dure, explaining the important hematoma after insertion. The
Nexplanon probably got through the upper limb veins, the right
heart chambers before stopping in the pulmonary artery (Fig. 6).
Instructions for insertion state that Nexplanon should be placed
subdermally at the inner side of the upper nondominant arm about
7 cm above the elbow crease in the groove between the biceps andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figs. 1-2. CXR showing a linear opaque structure in pulmonary hemi-right ﬁeld.
Fig. 4. Interventional technique: capture with a loop snare.
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arm limits implant migration [6]. By tenting the skin, the operator
should avoid a deep insertion and complications like endovascular
insertion.Fig. 3. Coronal thoracic CT scan with injection showing the Nexplanon in the upper right
lobar artery.In cases of troubles to locate a non-palpable implant before removal,
ultrasound guidance is recommended by ﬁrst intention with a nearly
100% efﬁciency [4]. It appears as a hyperechoic line with a posterior
shadow cone. Hormonal assay also conﬁrms or denies the presence of
the device. In case of a positive assay, the strategy was previously
based onMRI. Today, the use of Nexplanon, which is radiopaque, allows
the use of plain radiographies.
When radiography or CT scan of the upper limb fail, a more distant
migration has to be considered and chest radiograph should be
performed.
To our knowledge, only one case of distant pulmonary artery mi-
gration far from the insertion site has been reported, also diagnosed
by chest radiograph after an episode of chest pain [5]. In this case, no
information was reported about difﬁculties with insertion of the im-
plant. The device was lodged in a subsegmental branch of the left
lower lobe pulmonary artery. Options of retrieval were discussed,
but the patient opted against intervention. Endovascular removal
of a contraceptive implant in pulmonary artery has not been report-
ed before our case.
Cardiopulmonary complications after a contraceptive implant mi-
gration in pulmonary artery may be serious including infection and
thrombosis. Exact location is crucial as endovascular procedures are
now considered as the best way to retrieve endovascular foreign bodies
with high success rate and low morbidity.Fig. 5. Nexplanon after removal.
Fig. 6. Ride of the Nexplanon.
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